0R3M fundamentals
An in-depth look to VIVORYON THERAPEUTICS N.V. EUR0.01 operating, investing, and financing activities
0R3M free cash flow for H1 24 is -13.3 M EUR. For 2023, 0R3M free cash flow was -21.55 M EUR and operating cash flow was -21.54 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM